secwatch.observer — SEC 8-K summary
======================================

Issuer:     TANDEM DIABETES CARE INC (TNDM)
CIK:        0001438133
Form:       8-K
Filed at:   2023-05-26T23:59:59+00:00
Accession:  0001438133-23-000094
Event type: other
Sentiment:  neutral
Materiality: 0.25
Item codes: 5.07, 5.08
LLM model:  deepseek-v4-flash:cloud@v2

Tandem Diabetes annual meeting results: all director nominees elected, 2023 LTIP approved
--------------------------------------------------------------------------------

- Stockholders elected 7 directors; Blickenstaff, Cha, Howell, Malagueira, McGroddy-Goetz, Sheridan, Twomey.
- 2023 Long-Term Incentive Plan approved with 51.8M votes for, 4.1M against.
- Named executive officer compensation approved on advisory basis (45.7M for, 10.3M against).
- Ernst & Young ratified as auditor for FY2023 (58.1M for, 0.8M against).
- Deadline for Rule 14a-8 proposals for 2024 annual meeting: December 14, 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1438133/000143813323000094/0001438133-23-000094-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1438133/000143813323000094/tndm-20230524.htm
  HTML page:      https://secwatch.observer/filing/0001438133-23-000094

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer